None
Quote | Sutro Biopharma Inc. (NASDAQ:STRO)
Last: | $3.83 |
---|---|
Change Percent: | -3.05% |
Open: | $4.06 |
Close: | $3.83 |
High: | $4.13 |
Low: | $3.81 |
Volume: | 622,024 |
Last Trade Date Time: | 05/03/2024 03:00:00 am |
News | Sutro Biopharma Inc. (NASDAQ:STRO)
– Part 2 of REFRαME-O1, the registration-directed study of luvelta for patients with platinum-resistant ovarian cancer (PROC), is open for enrollment – – Planned 50 patients in Dose-Optimization (Part 1) of REFRαME-O1 have been enrolled and are in foll...
2024-04-17 17:01:03 ET Gainers: Vanda Pharmaceuticals ( VNDA ) +7% . Sutro Biopharma ( STRO ) +5% . CureVac ( CVAC ) +5% . CorMedix ( CRMD ) +4% . Bank OZK ( OZK ) +4% . Losers: Omega Therapeutics ( OM...
Message Board Posts | Sutro Biopharma Inc. (NASDAQ:STRO)
Subject | By | Source | When |
---|---|---|---|
AviseAnalytics: 4 BIOTECH STOCKS THAT WARRANT YOUR ATTENTION! $STRO $MTEM $SNDX $KRYS Clinical-Stag | AviseAnalytics | investorshangout | 10/05/2021 12:40:31 PM |
News, Short Squeeze, Breakout and More Instantly...
– Part 2 of REFRαME-O1, the registration-directed study of luvelta for patients with platinum-resistant ovarian cancer (PROC), is open for enrollment – – Planned 50 patients in Dose-Optimization (Part 1) of REFRαME-O1 have been enrolled and are in foll...
2024-04-03 17:00:02 ET Jay Olson from Oppenheimer issued a price target of $10.00 for STRO on 2024-04-03 14:01:00. The adjusted price target was set to $10.00. At the time of the announcement, STRO was trading at $5.09. The overall price target consensus is at $14.50 wit...
2024-04-03 08:00:08 ET Edward Tenthoff from Piper Sandler issued a price target of $11.00 for STRO on 2024-04-03 06:48:00. The adjusted price target was set to $11.00. At the time of the announcement, STRO was trading at $5.09. The overall price target consensus is at $1...